ImmuneoACT shared a post on X:
“780+ days. In complete remession.
This National Cancer Survivors Day, we’re proud to share Pradeep’s story. A national-level cyclist with an active lifestyle, Pradeep suddenly found himself facing an unexpected diagnosis of B-cell Acute Lymphoblastic Leukemia (B-ALL). What followed was a challenging treatment journey marked by resilience, determination, and hope.
After relapsing two years following multiple lines of therapy, Pradeep received NexCAR19™ in 2024. Today, he has completed more than 780 days in complete remission. He is back to enjoying everyday moments, staying active, and looking ahead with renewed confidence.
NexCAR19 has now treated more than 750 patients with B-cell malignancies, making advanced CAR-T cell therapy more accessible to patients across India. Pradeep is one of the 100+ patients who have sustained complete remission for over a year- demonstrating the potential durability of response that NexCAR19 can provide.
This National Cancer Survivors Day and Cancer Immunotherapy Month, we celebrate every survivor and every milestone. Pradeep’s journey is a reminder of how resilience, innovation, and access to advanced therapies can help create new possibilities for patients facing blood cancer. Want to hear Pradeep share his journey in his own words?”
Other articles about Immunotherapy on OncoDaily.